Neda Safarzadeh | Vice President, Head-Investor Relations, Public Relations and Marketing |
Joseph Payne | President and Chief Executive Officer |
Andy Sassine | Chief Financial Officer |
Pad Chivukula | Chief Scientific Officer and Chief Operating Officer |
Yasmeen Rahimi | Piper Sandler |
Pete Stavropoulos | Cantor Fitzgerald |
Evan Wang | Guggenheim Securities |
Carly Kenselaar | Citi |
Yanan Zhu | Wells Fargo Securities |
Yale Jen | Laidlaw & Company |
Good afternoon, ladies and gentlemen, and welcome to the Arcturus Therapeutics First Quarter 2023 Earnings Conference Call. At this time, all lines are in a listen-only mode.
Following the presentation, we’ll conduct a question-and-answer session. [Operator Instructions] This call is being recorded on Tuesday, May 9, 2023.
I would now like to turn the conference over to Neda Safarzadeh, Vice President, Head of Investor Relations, Public Relations and Marketing.